{"id":"https://openalex.org/W2183798533","doi":null,"title":"HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.","display_name":"HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2183798533","mag":"2183798533","pmid":"https://pubmed.ncbi.nlm.nih.gov/16739334"},"language":"en","primary_location":{"id":"pmid:16739334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16739334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012112204","display_name":"Dimitrios G. Pectasides","orcid":"https://orcid.org/0000-0002-2102-2167","observed_orcids":["https://orcid.org/0000-0002-2102-2167"]},"institutions":[{"id":"https://openalex.org/I4210140282","display_name":"University General Hospital Attikon","ror":"https://ror.org/03gb7n667","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210140282"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"D Pectasides","raw_affiliation_strings":["Second Department of Internal Medicine, Propaedeutic, Oncology Section, Attikon University Hospital, Athens, Greece. pectasid@otenet.gr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Internal Medicine, Propaedeutic, Oncology Section, Attikon University Hospital, Athens, Greece. pectasid@otenet.gr","institution_ids":["https://openalex.org/I4210140282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049884069","display_name":"A. Gaglia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Gaglia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034349384","display_name":"Petroula Arapantoni-Dadioti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Arapantoni-Dadioti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045428658","display_name":"A. Bobota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Bobota","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077314116","display_name":"Christos Valavanis","orcid":"https://orcid.org/0009-0003-2809-2787","observed_orcids":["https://orcid.org/0009-0003-2809-2787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Valavanis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075487814","display_name":"Vassiliki Kostopoulou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Kostopoulou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029045590","display_name":"Nicolas Mylonakis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Mylonakis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028501800","display_name":"Athanasios Karabelis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Karabelis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030378527","display_name":"Melina Pectasides","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Pectasides","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004755929","display_name":"Theofanis Economopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Economopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6834,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.84218513,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"26","issue":"1B","first_page":"647","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9089999794960022},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9100000262260437},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7570000290870667},{"id":"https://openalex.org/keywords/chromogenic-in-situ-hybridization","display_name":"chromogenic in situ hybridization","score":0.7699999809265137},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8510000109672546},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.5830000042915344},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5389999747276306},{"id":"https://openalex.org/keywords/her-2-neu-overexpression","display_name":"HER-2/neu overexpression","score":0.5239999890327454},{"id":"https://openalex.org/keywords/trastuzumab-resistance","display_name":"trastuzumab resistance","score":0.7260000109672546},{"id":"https://openalex.org/keywords/metastasis-free-survival","display_name":"metastasis-free survival","score":0.3230000138282776},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.460999995470047},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C121313828","wikidata":"https://www.wikidata.org/wiki/Q17861998","display_name":"CISH","level":5,"score":0.9536137580871582},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8965873718261719},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8547974824905396},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.754273533821106},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6892914772033691},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6691325902938843},{"id":"https://openalex.org/C2776643354","wikidata":"https://www.wikidata.org/wiki/Q5113886","display_name":"Chromogenic in situ hybridization","level":5,"score":0.625575065612793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5193058848381042},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5000617504119873},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48444274067878723},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.46710243821144104},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.42407795786857605},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.4214095175266266},{"id":"https://openalex.org/C81439078","wikidata":"https://www.wikidata.org/wiki/Q2304142","display_name":"In situ hybridization","level":4,"score":0.1044195294380188},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05526155233383179},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16739334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16739334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2183798533","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16739334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W112854329","https://openalex.org/W1971272994","https://openalex.org/W1977958044","https://openalex.org/W1993135703","https://openalex.org/W2016185092","https://openalex.org/W2060368924","https://openalex.org/W2066051514","https://openalex.org/W2069237867","https://openalex.org/W2069548442","https://openalex.org/W2094841890","https://openalex.org/W2110442763","https://openalex.org/W2112695753","https://openalex.org/W2113546227","https://openalex.org/W2128448303","https://openalex.org/W2129134252","https://openalex.org/W2137399990","https://openalex.org/W2140737084","https://openalex.org/W2141393790","https://openalex.org/W2151809511","https://openalex.org/W2159459001","https://openalex.org/W2167167632","https://openalex.org/W2168106779","https://openalex.org/W2222638000","https://openalex.org/W2318605753","https://openalex.org/W2331628684","https://openalex.org/W2409943266"],"related_works":["https://openalex.org/W2246066141","https://openalex.org/W2471069586","https://openalex.org/W1599285204","https://openalex.org/W2341876208","https://openalex.org/W2058370043","https://openalex.org/W2066974341","https://openalex.org/W1986291899","https://openalex.org/W2145699015","https://openalex.org/W198094304","https://openalex.org/W2060368924"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,32,136,232],"aim":[2],"of":[3,34,89,161,219,223,228,262,274,290,297,372],"this":[4,382],"prospective":[5],"study":[6],"was":[7,42,201,282,312,366],"to":[8,117,252,308,388],"investigate":[9],"whether":[10,381],"there":[11],"were":[12,54,74,98,114,138,214],"changes":[13],"in":[14,17,25,39,69,76,133,154,189,216,244,287,315,362],"HER-2/neu":[15,38,111,146,152,166,173,196,199,225,230,268,278,318,325,332,354,375],"status":[16,200],"newly-developed":[18,90,168,363],"metastatic":[19,91,156,169,347,364],"lesions":[20,92,170,365],"following":[21,93],"treatment":[22,123,298],"with":[23,50,144,150,266,276,299,346,351],"trastuzumab":[24,94,253,300],"advanced":[26],"breast":[27,348],"cancer":[28,349],"patients":[29,41,49,80,85,137,221,248,265,320,345],"overexpressing":[30],"HER-2/neu.":[31],"utility":[33],"serological":[35],"assays":[36],"for":[37,100,323,330,343],"such":[40],"also":[43],"studied.":[44],"PATIENTS":[45],"AND":[46],"METHODS:":[47],"Sixteen":[48],"HER-2/neu-overexpressing":[51],"tumors":[52],"(15":[53],"3+":[55],"by":[56,62,66,102,105,124,180,204,358],"immunohistochemistry":[57],"(IHC)":[58],"and":[59,64,83,104,120,148,175,238,329],"one":[60],"2+":[61],"IHC":[63,103,181,205,359],"positive":[65,208],"the":[67,77,106,155,162,185,190,198,241,256,259,263,288,294,304,316,353],"chromogenic":[68],"situ":[70],"hybridization":[71],"(CISH)":[72],"test)":[73],"included":[75],"study.":[78],"Fourteen":[79],"underwent":[81],"biopsy":[82],"2":[84,141,227,275,305],"fine-needle":[86],"aspiration":[87],"(FNA)":[88],"treatment.":[95,254],"All":[96],"samples":[97],"assayed":[99],"HER-2":[101,234],"CISH":[107,186,209,361],"test.":[108],"Serial":[109],"serum":[110,233],"(S-HER-2)":[112,235],"levels":[113,213,236,261],"measured":[115,357],"prior":[116],"(baseline":[118],"values)":[119],"during":[121],"trastuzumab-based":[122],"enzyme-linked":[125],"immunosorbent":[126],"assay":[127],"(ELISA)":[128],"(cut-off":[129],"point:":[130],"10":[131],"ng/ml)":[132],"all":[134,245],"patients.":[135],"divided":[139],"into":[140],"groups:":[142],"those":[143,149,273],"\"altered":[145,224,267,317,324],"status\"":[147,153,269,279,319],"\"conserved":[151,229,277,331],"region.":[157],"RESULTS:":[158],"Six":[159],"out":[160,218],"16":[163,220],"(37%)":[164],"(\"altered":[165],"status\")":[167],"lost":[171,374],"their":[172],"overexpression":[174],"scored":[176],"0":[177],"or":[178,182,206,293,301,386],"+1":[179],"negative":[183],"on":[184],"test,":[187],"while":[188,272],"remaining":[191],"cases":[192,373],"(10/16,":[193],"62.5%)":[194],"(\"conserved":[195],"status\"),":[197],"unchanged":[202],"(+3":[203],"a":[207,250,369],"test).":[210],"Baseline":[211],"S-HER-2":[212,260],"elevated":[215],"5":[217,247],"(3":[222],"status\",":[226],"status\").":[231],"declined":[237],"returned":[239],"within":[240],"normal":[242],"ranges":[243],"these":[246],"as":[249,356],"response":[251],"Following":[255],"disease":[257],"progression,":[258],"3":[264],"remained":[270],"normal,":[271],"increased.":[280],"There":[281],"no":[283],"statistically":[284],"significant":[285],"difference":[286],"number":[289],"chemotherapeutic":[291],"treatments":[292],"median":[295],"time":[296],"chemotherapy":[302],"between":[303],"groups.":[306],"Time":[307],"tumor":[309],"progression":[310],"(TTP)":[311],"significantly":[313],"shorter":[314],"(median":[321],"TTP":[322],"status\":":[326,333],"9.5":[327],"months,":[328],"12":[334],"months;":[335],"p":[336],"<0.001).":[337],"CONCLUSION:":[338],"These":[339],"data":[340],"suggest":[341],"that,":[342],"most":[344],"treated":[350],"trastuzumab,":[352],"expression":[355],"and/or":[360],"unchanged.":[367],"However,":[368],"remarkable":[370],"percentage":[371],"overexpression.":[376],"It":[377],"is":[378],"not":[379],"clear":[380],"finding":[383],"implies":[384],"resistance":[385],"sensitivity":[387],"trastuzumab.":[389]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":13}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}